Attached files

file filename
S-1/A - S-1/A - Acer Therapeutics Inc.d848715ds1a.htm
EX-1.1 - EX-1.1 - Acer Therapeutics Inc.d848715dex11.htm
EX-99.4 - EX-99.4 - Acer Therapeutics Inc.d848715dex994.htm
EX-99.1 - EX-99.1 - Acer Therapeutics Inc.d848715dex991.htm
EX-4.13 - EX-4.13 - Acer Therapeutics Inc.d848715dex413.htm
EX-4.10 - EX-4.10 - Acer Therapeutics Inc.d848715dex410.htm
EX-99.5 - EX-99.5 - Acer Therapeutics Inc.d848715dex995.htm
EX-23.1 - EX-23.1 - Acer Therapeutics Inc.d848715dex231.htm
EX-99.3 - EX-99.3 - Acer Therapeutics Inc.d848715dex993.htm
EX-99.2 - EX-99.2 - Acer Therapeutics Inc.d848715dex992.htm
EX-99.7 - EX-99.7 - Acer Therapeutics Inc.d848715dex997.htm

Exhibit 99.6

FORM OF

NOMINEE HOLDER CERTIFICATION

OPEXA THERAPEUTICS, INC.

The undersigned, a bank, broker, dealer, trustee, depositary, or other nominee of non-transferable subscription rights (the “Subscription Rights”) to purchase units (“Units”) of Opexa Therapeutics, Inc. (the “Company”), said Units each comprised of one share of common stock (“Common Stock”) and one warrant to purchase an additional share of Common Stock (a “Warrant”) pursuant to the Subscription Rights offering described and provided for in the Company’s Prospectus dated [          ], 2015, hereby certifies to the Company and to Continental Stock Transfer & Trust Company, as Subscription Agent for such Rights Offering, that (1) the undersigned has exercised, on behalf of the beneficial owners thereof (which may include the undersigned), the number of Subscription Rights specified below pursuant to the Basic Subscription Right (as defined in the Prospectus) and, on behalf of beneficial owners of Subscription Rights who have subscribed for the purchase of additional Units pursuant to the Over-Subscription Privilege (as defined in the Prospectus), the number of Units specified below, listing separately below each such exercised Basic Subscription Right and the corresponding Over-Subscription Privilege (without identifying any such beneficial owner), and (2) to the extent a beneficial owner has elected to subscribe for Units pursuant to the Over-Subscription Privilege, each such beneficial owner’s Basic Subscription Right has been exercised in full:

 

  Number of Shares Owned  

on the Record Date

  Number of Units Subscribed for  

Pursuant to the

Basic Subscription Right

  Number of Units Subscribed for  

Pursuant to the

Over-Subscription Privilege

1.
2.
3.
4.
5.
6.
7.
8.

 

 

Name of Nominee Holder
By:

 

Name:

 

Title:

 

Phone Number:

 

Fax Number:

 

Dated:

 

Provide the following information, if applicable:

 

DTC Participant Number

 

DTC Participant
By:

 

Name:

 

Title:

 

 

DTC Basic Subscription
Confirmation Number(s)
Dated: